Respiratory tract infection: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (→Treatment: added zinc) |
mNo edit summary |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 18: | Line 18: | ||
==Diagnosis== | ==Diagnosis== | ||
The [[United States]] [[Food and Drug Administration]] has approved xTAG™ Respiratory Viral Panel (RVP) for detecting viral causes.<ref name="urlK063765">{{cite web |url=http://www.fda.gov/cdrh/mda/docs/K063765.html |title=New Device Approval - xTAG™ Respiratory Viral Panel (RVP) - K063765 |author=Anonymous |authorlink= |coauthors= |date=2008 |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2008-11-04}}</ref> | The [[United States of America]] [[Food and Drug Administration]] has approved xTAG™ Respiratory Viral Panel (RVP) for detecting viral causes.<ref name="urlK063765">{{cite web |url=http://www.fda.gov/cdrh/mda/docs/K063765.html |title=New Device Approval - xTAG™ Respiratory Viral Panel (RVP) - K063765 |author=Anonymous |authorlink= |coauthors= |date=2008 |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2008-11-04}}</ref> | ||
==Treatment== | ==Treatment== | ||
[[Zinc]] may reduce the duration and severity of symptoms | Antibiotic therapy did not help in a study of patients who mainly had bronchitis.<ref name="pmid23265995">{{cite journal| author=Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M et al.| title=Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. | journal=Lancet Infect Dis | year= 2012 | volume= | issue= | pages= | pmid=23265995 | doi=10.1016/S1473-3099(12)70300-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23265995 }} </ref> About 15% had chronic obstructive lung disease and their results were not reported separately.<ref name="pmid23265995"/> | ||
[[Zinc]], 10-13 mg lozenges every two to three hours while awake, may reduce the duration and severity of symptoms according to a [[meta-analysis]]<ref>{{Cite book | publisher = John Wiley & Sons, Ltd | editors = The Cochrane Collaboration, Meenu Singh (eds.) | last = Singh | first = Meenu | coauthors = Rashmi R Das | title = Cochrane Database of Systematic Reviews | chapter = Zinc for the common cold | location = Chichester, UK | accessdate = 2011-02-17 | date = 2011 | chapterurl = http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD001364/abstract.html }}</ref> by the [[Cochrane Collaboration]] of [[randomized controlled trial]]s<ref name="pmid8678384">{{cite journal| author=Mossad SB, Macknin ML, Medendorp SV, Mason P| title=Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. | journal=Ann Intern Med | year= 1996 | volume= 125 | issue= 2 | pages= 81-8 | pmid=8678384 | doi= | pmc= | url= }} </ref><ref name="pmid10929163">{{cite journal| author=Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH| title=Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. | journal=Ann Intern Med | year= 2000 | volume= 133 | issue= 4 | pages= 245-52 | pmid=10929163 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10929163 }} </ref><ref name="pmid9643859">{{cite journal| author=Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E| title=Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. | journal=JAMA | year= 1998 | volume= 279 | issue= 24 | pages= 1962-7 | pmid=9643859 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9643859 }} </ref>. [[Drug toxicity]] includes [[nausea]], [[taste disorder]]s, and [[diarrhea]]; however, some toxicity may be due to ligands rather than zinc.<ref name="pmid8678384"/><ref name="pmid9643859"/> | |||
[[Guaifenesin]] may reduce cough.<ref name="pmid18253996">{{cite journal| author=Smith SM, Schroeder K, Fahey T| title=Over-the-counter medications for acute cough in children and adults in ambulatory settings. | journal=Cochrane Database Syst Rev | year= 2008 | volume= | issue= 1 | pages= CD001831 | pmid=18253996 | [[Guaifenesin]] may reduce cough.<ref name="pmid18253996">{{cite journal| author=Smith SM, Schroeder K, Fahey T| title=Over-the-counter medications for acute cough in children and adults in ambulatory settings. | journal=Cochrane Database Syst Rev | year= 2008 | volume= | issue= 1 | pages= CD001831 | pmid=18253996 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=18253996 | doi=10.1002/14651858.CD001831.pub3 }} </ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=18253996 | doi=10.1002/14651858.CD001831.pub3 }} </ref> | ||
==Prognosis== | |||
The cough may last 18 days according to a [[systematic review]].<ref name="pmid23319500">{{Cite journal | |||
| doi = 10.1097/ACM.0b013e318244759e | issn = 1040-2446 | volume = 87 | issue = 3 | pages = 292-299 | last = Haidet | first = Paul | coauthors = Ruth E. Levine, Dean X. Parmelee, Sheila Crow, Frances Kennedy, P. Adam Kelly, Linda Perkowski, Larry Michaelsen, Boyd F. Richards | title = Perspective | journal = Academic Medicine | accessdate = 2012-03-07 | date = 2012-03 | pmid=23319500 | doi=10.1370/afm.1430 }}</ref> | |||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:00, 11 October 2024
| Respiratory tract infection | |
|---|---|
| MeSH | D012141 |
In medicine, respiratory tract infections include any infection of the respiratory tract. Examples include the common cold, pharyngitis, sinusitis, bronchitis, pneumonia.
Infections may involve more than one location of the respiratory tract. For example, about half of patients with pharyngitis also have coryza[1] and half of patients with sinusitis complain of sore throat[2].
Common organisms causing the infections include influenza.
Diagnosis
The United States of America Food and Drug Administration has approved xTAG™ Respiratory Viral Panel (RVP) for detecting viral causes.[3]
Treatment
Antibiotic therapy did not help in a study of patients who mainly had bronchitis.[4] About 15% had chronic obstructive lung disease and their results were not reported separately.[4]
Zinc, 10-13 mg lozenges every two to three hours while awake, may reduce the duration and severity of symptoms according to a meta-analysis[5] by the Cochrane Collaboration of randomized controlled trials[6][7][8]. Drug toxicity includes nausea, taste disorders, and diarrhea; however, some toxicity may be due to ligands rather than zinc.[6][8]
Guaifenesin may reduce cough.[9]
Prognosis
The cough may last 18 days according to a systematic review.[10]
References
- ↑ Ebell MH, Smith MA, Barry HC, Ives K, Carey M (2000). "The rational clinical examination. Does this patient have strep throat?". JAMA 284 (22): 2912-8. PMID 11147989. [e]
- ↑ Williams JW, Simel DL (1993). "Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination.". JAMA 270 (10): 1242-6. PMID 8355389. [e]
- ↑ Anonymous (2008). New Device Approval - xTAG™ Respiratory Viral Panel (RVP) - K063765. Food and Drug Administration. Retrieved on 2008-11-04.
- ↑ 4.0 4.1 Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M et al. (2012). "Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial.". Lancet Infect Dis. DOI:10.1016/S1473-3099(12)70300-6. PMID 23265995. Research Blogging.
- ↑ Singh, Meenu; Rashmi R Das (2011). “Zinc for the common cold”, Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. Retrieved on 2011-02-17.
- ↑ 6.0 6.1 Mossad SB, Macknin ML, Medendorp SV, Mason P (1996). "Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.". Ann Intern Med 125 (2): 81-8. PMID 8678384. [e]
- ↑ Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH (2000). "Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.". Ann Intern Med 133 (4): 245-52. PMID 10929163. [e]
- ↑ 8.0 8.1 Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E (1998). "Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial.". JAMA 279 (24): 1962-7. PMID 9643859. [e]
- ↑ Smith SM, Schroeder K, Fahey T (2008). "Over-the-counter medications for acute cough in children and adults in ambulatory settings.". Cochrane Database Syst Rev (1): CD001831. DOI:10.1002/14651858.CD001831.pub3. PMID 18253996. Research Blogging.
- ↑ Haidet, Paul; Ruth E. Levine, Dean X. Parmelee, Sheila Crow, Frances Kennedy, P. Adam Kelly, Linda Perkowski, Larry Michaelsen, Boyd F. Richards (2012-03). "Perspective". Academic Medicine 87 (3): 292-299. DOI:10.1370/afm.1430. ISSN 1040-2446. PMID 23319500. Retrieved on 2012-03-07. Research Blogging.